Skip to main navigation
Skip to search
Skip to main content
The Aga Khan University Home
Search content at The Aga Khan University
Home
Profiles
Research units
Research output
Pharmacologic management of PCOS: Menstrual irregularities
Farheen Yousuf
,
Rehana Rehman
Department of Biological & Biomedical Sciences, Medical College, Pakistan
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacologic management of PCOS: Menstrual irregularities'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Androgen
25%
Anovulation
50%
Antiandrogen
25%
Cancer
25%
Cell Proliferation
25%
Cyproterone
25%
Diethylstilbestrol
25%
Drospirenone
25%
Endometrial Hyperplasia
25%
Estradiol Valerate
25%
Follitropin
25%
Glycon
25%
Hyperandrogenism
50%
Inositol
25%
Insulin Resistance
25%
Insulin Sensitizing Agent
25%
Lifestyle Modification
25%
Luteinizing Hormone
25%
Menstrual Cycle
50%
Menstrual Irregularity
100%
Menstruation Disorder
25%
Oral Contraceptive Agent
100%
Polycystic Ovary Syndrome
100%
Progesterone
75%
Side Effect
25%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen
25%
Anovulation
50%
Antiandrogen
25%
Cyproterone
25%
Diethylstilbestrol
25%
Drospirenone
25%
Endometrium Hyperplasia
25%
Estradiol Valerate
25%
Follitropin
25%
Hyperandrogenism
50%
Inositol
25%
Insulin Resistance
25%
Insulin Sensitizing Agent
25%
Luteinizing Hormone
25%
Menstrual Irregularity
100%
Menstruation Disorder
25%
Metformin
25%
Oral Contraceptive Agent
100%
Ovary Polycystic Disease
100%
Progesterone
75%
Side Effect
25%
Agricultural and Biological Sciences
Androgen
25%
Anovulation
50%
Cell Proliferation
25%
Combined Oral Contraceptive Pill
100%
Cyproterone
25%
Diethylstilbestrol
25%
Drospirenone
25%
Estradiol Valerate
25%
Follicle-Stimulating Hormone
25%
Hyperandrogenism
50%
Inositol
25%
Insulin Resistance
25%
Luteinizing Hormone
25%
Menstrual Cycle
50%
Progesterone
75%
Veterinary Science and Veterinary Medicine
Hyperplasia
25%